HTA - 11/129/16

Does vertebral stenting prevent recurrent stroke in symptomatic vertebral artery stenosis: The Vertebral artery Ischaemia Stenting Trial (VIST)

Project title: Does vertebral stenting prevent recurrent stroke in symptomatic vertebral artery stenosis: The Vertebral artery Ischaemia Stenting Trial (VIST)

Call to action: 11/129 Rapid trials to inform clinical decision making in the NHS

Research type: Primary Research

Chief investigator: Professor Hugh Markus

Lead Author: Professor Hugh Markus

Contractor: University of Cambridge

Cost: £380,582.97

Co-investigators: Dr Andrew Clifton, Dr Ursula Schulz, Dr Wilhelm Küker, Mr John Dennis, Ms Caroline Murphy, Professor Ian Ford, Professor Peter Rothwell, Professor Stephen Morris.

Started: March 2013 | Status: Published August 2019

ISRCTN: 95212240

This trial did not recruit the planned number of patients or show that vertebral stenting reduced the risk of stroke.

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.